Web NewDrugInformation.com

Cardioplegic In Plastic Container Drug - Cardioplegic In Plastic Container The trade name of the product as shown on the labeling. Dosage - SOLUTION; PERFUSION, CARDIAC The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Calcium Chloride; Magnesium Chloride; Potassium Chloride; Sodium Chloride Multiple ingredients are in alphabetical order. Strength - 17.6MG/100ML;325.3MG/100ML;119.3MG/100ML;643MG/100ML The potency of the active ingredient(s), Calcium Chloride; Magnesium Chloride; Potassium Chloride; Sodium Chloride. May repeat for multiple part products. Applicant - BAXTER HLTHCARE The firm name holding legal responsibility for Cardioplegic In Plastic Container. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 075323 The FDA assigned number to Cardioplegic In Plastic Container. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Cardioplegic In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AT The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Apr 21, 2000 The date Cardioplegic In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Cardioplegic In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Cardioplegic In Plastic Container is in. Format is RX, OTC, DISCN. Applicant Full Name - Baxter Healthcare Corp The full name of the firm holding legal responsibility for the new application of Cardioplegic In Plastic Container. Cardioplegic In Plastic Container Isolyte E In Plastic Container 35mg/100ml;30mg/100ml;74mg/100ml;640mg/100ml;500mg/100ml;74mg/100ml Injectable; Injection Bss 0.48mg/ml;0.3mg/ml;0.75mg/ml;3.9mg/ml;6.4mg/ml;1.7mg/ml Solution; Irrigation Plasma-lyte R In Plastic Container 36.8mg/100ml;30.5mg/100ml;74.6mg/100ml;640mg/100ml;496mg/100ml;89.6mg/100ml Injectable; Injection Cardioplegic In Plastic Container 17.6mg/100ml;325.3mg/100ml;119.3mg/100ml;643mg/100ml Solution; Perfusion, Cardiac Inpersol-zm W/ Dextrose 1.5% In Plastic Container 25.7mg/100ml;1.5gm/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-zm W/ Dextrose 2.5% In Plastic Container 25.7mg/100ml;2.5gm/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-zm W/ Dextrose 4.25% In Plastic Container 25.7mg/100ml;4.25gm/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Tpn Electrolytes In Plastic Container 16.5mg/ml;25.4mg/ml;74.6mg/ml;121mg/ml;16.1mg/ml Injectable; Injection Tpn Electrolytes In Plastic Container 16.5mg/ml;25.4mg/ml;74.6mg/ml;121mg/ml;16.1mg/ml Injectable; Injection Isolyte E In Plastic Container 35mg/100ml;30mg/100ml;74mg/100ml;640mg/100ml;500mg/100ml;74mg/100ml Injectable; Injection NewDrugInformation